ARTICLE | Company News
Sysmex Corp., Merck KGaA deal
June 9, 2014 7:00 AM UTC
Merck exclusively partnered with Sysmex's Sysmex Inostics GmbH subsidiary to develop and commercialize a blood-based Ras biomarker test worldwide for patients with metastatic colorectal cancer (mCRC)...